Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | %Female (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
99 | Phytochemical Analysis | journal | 0.723 Q3 | 83 | 68 | 207 | 1568 | 356 | 206 | 1.78 | 23.06 | 37.72 | |
98 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.724 Q3 | 45 | 31 | 89 | 2650 | 210 | 88 | 2.28 | 85.48 | 41.49 | |
97 | Genetic Vaccines and Therapy | journal | 0.729 Q3 | 30 | 12 | 32 | 461 | 82 | 32 | 2.43 | 38.42 | 45.78 | |
96 | Human Genomics | journal | 0.735 Q3 | 68 | 43 | 43 | 720 | 63 | 32 | 1.20 | 16.74 | 36.04 | |
95 | Nuclear Medicine and Biology | journal | 0.738 Q3 | 98 | 112 | 364 | 3445 | 960 | 353 | 2.67 | 30.76 | 27.20 | |
94 | Progress in Medicinal Chemistry | journal | 0.746 Q3 | 38 | 14 | 21 | 961 | 36 | 17 | 1.92 | 68.64 | 23.08 | |
93 | Molecular Diagnosis and Therapy | journal | 0.754 Q3 | 68 | 34 | 123 | 2398 | 314 | 117 | 2.54 | 70.53 | 40.00 | |
92 | Planta Medica | journal | 0.777 Q3 | 135 | 244 | 742 | 6120 | 1630 | 735 | 2.01 | 25.08 | 36.24 | |
91 | Bioinspiration and Biomimetics | journal | 0.806 Q3 | 87 | 26 | 90 | 931 | 268 | 86 | 2.80 | 35.81 | 18.87 | |
90 | Molecular Informatics | journal | 0.830 Q3 | 75 | 124 | 289 | 4213 | 839 | 278 | 3.06 | 33.98 | 32.35 | |
89 | Expert Review of Molecular Diagnostics | journal | 0.854 Q3 | 89 | 76 | 231 | 5722 | 824 | 205 | 3.40 | 75.29 | 29.82 | |
88 | Assay and Drug Development Technologies | journal | 0.859 Q3 | 65 | 43 | 286 | 1203 | 419 | 162 | 1.33 | 27.98 | 25.00 | |
87 | Viral Immunology | journal | 0.864 Q3 | 70 | 58 | 204 | 1894 | 423 | 196 | 1.72 | 32.66 | 40.27 | |
86 | Phytomedicine | journal | 0.890 Q3 | 141 | 158 | 427 | 4522 | 1273 | 414 | 2.81 | 28.62 | 38.03 | |
85 | Molecular Oncology | journal | 0.952 Q3 | 113 | 51 | 87 | 2421 | 129 | 58 | 1.48 | 47.47 | 34.78 | |
84 | Chemical Biology and Drug Design | journal | 0.964 Q2 | 91 | 148 | 336 | 5442 | 900 | 325 | 2.52 | 36.77 | 35.11 | |
83 | Mini-Reviews in Medicinal Chemistry | journal | 0.984 | 107 | 149 | 394 | 14757 | 1314 | 391 | 3.26 | 99.04 | 33.26 | |
82 | Nucleic Acid Therapeutics | journal | 1.042 Q2 | 77 | 38 | 109 | 1479 | 284 | 107 | 2.72 | 38.92 | 39.51 | |
81 | Vascular Pharmacology | journal | 1.049 Q2 | 108 | 79 | 272 | 3287 | 744 | 266 | 2.18 | 41.61 | 35.37 | |
80 | Pharmacogenomics | journal | 1.051 Q2 | 100 | 184 | 468 | 8961 | 1614 | 412 | 3.35 | 48.70 | 38.72 | |
79 | Molecular Imaging | journal | 1.054 Q2 | 66 | 32 | 98 | 1214 | 344 | 97 | 3.27 | 37.94 | 31.16 | |
78 | Journal of Biomolecular Screening | journal | 1.067 Q2 | 86 | 117 | 306 | 2914 | 820 | 304 | 2.56 | 24.91 | 30.22 | |
77 | Journal of Steroid Biochemistry and Molecular Biology | journal | 1.068 Q2 | 144 | 142 | 605 | 6370 | 1883 | 598 | 3.02 | 44.86 | 44.84 | |
76 | Journal of Pharmacological Sciences | journal | 1.081 Q2 | 101 | 199 | 557 | 6895 | 1539 | 551 | 2.39 | 34.65 | 26.96 | |
75 | Extremophiles | journal | 1.095 Q2 | 95 | 86 | 239 | 3524 | 558 | 237 | 2.17 | 40.98 | 40.14 | |
74 | Experimental and Molecular Medicine | journal | 1.096 Q2 | 115 | 100 | 251 | 3482 | 654 | 251 | 2.51 | 34.82 | 36.70 | |
73 | AIDS Research and Therapy | journal | 1.112 Q2 | 49 | 30 | 82 | 891 | 210 | 82 | 2.81 | 29.70 | 35.24 | |
72 | Bioorganic and Medicinal Chemistry Letters | journal | 1.123 Q2 | 166 | 1487 | 3860 | 39170 | 11088 | 3859 | 2.88 | 26.34 | 31.61 | |
71 | Bioorganic and Medicinal Chemistry | journal | 1.130 Q2 | 187 | 887 | 2542 | 33854 | 8211 | 2539 | 3.03 | 38.17 | 34.14 | |
70 | Infectious Disorders - Drug Targets | journal | 1.170 Q2 | 61 | 53 | 96 | 5332 | 289 | 86 | 2.78 | 100.60 | 30.36 | |
69 | Progress in Molecular Biology and Translational Science | journal | 1.174 Q2 | 113 | 75 | 38 | 11602 | 77 | 38 | 0.73 | 154.69 | 38.33 | |
68 | Advances in Biological Regulation | journal | 1.184 Q2 | 69 | 22 | 69 | 1210 | 155 | 66 | 1.42 | 55.00 | 47.78 | |
67 | ChemMedChem | journal | 1.205 Q2 | 119 | 218 | 530 | 9458 | 1780 | 522 | 3.35 | 43.39 | 35.49 | |
66 | OMICS A Journal of Integrative Biology | journal | 1.224 Q2 | 69 | 49 | 111 | 2139 | 377 | 108 | 2.69 | 43.65 | 37.45 | |
65 | Blood Cells, Molecules, and Diseases | journal | 1.227 Q2 | 98 | 100 | 321 | 3869 | 931 | 294 | 2.96 | 38.69 | 47.72 | |
64 | Current Opinion in Molecular Therapeutics | journal | 1.249 Q2 | 67 | 77 | 212 | 5421 | 730 | 194 | 3.72 | 70.40 | 27.56 | |
63 | Journal of Gene Medicine | journal | 1.260 Q2 | 100 | 112 | 357 | 3924 | 1200 | 356 | 3.27 | 35.04 | 40.09 | |
62 | Expert Review of Vaccines | journal | 1.278 Q2 | 105 | 156 | 310 | 11295 | 1142 | 276 | 3.97 | 72.40 | 37.27 | |
61 | Cancer Biology and Therapy | journal | 1.280 Q2 | 130 | 370 | 993 | 13363 | 2380 | 759 | 2.28 | 36.12 | 37.83 | |
60 | Molecular Interventions | journal | 1.281 Q2 | 78 | 38 | 112 | 1415 | 370 | 104 | 2.92 | 37.24 | 31.15 | |
59 | Cancer Gene Therapy | journal | 1.359 Q2 | 99 | 91 | 298 | 4041 | 1042 | 295 | 3.43 | 44.41 | 35.32 | |
58 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.424 Q2 | 108 | 93 | 182 | 9648 | 833 | 167 | 4.33 | 103.74 | 30.12 | |
57 | Vaccine | journal | 1.453 Q2 | 215 | 1232 | 3072 | 45770 | 11876 | 2916 | 3.78 | 37.15 | 41.97 | |
56 | Journal of Natural Products | journal | 1.466 Q2 | 161 | 421 | 1228 | 11749 | 4067 | 1222 | 3.37 | 27.91 | 36.88 | |
55 | Expert Opinion on Therapeutic Targets | journal | 1.469 Q2 | 106 | 116 | 345 | 11796 | 1225 | 321 | 3.82 | 101.69 | 30.38 | |
54 | Journal of Nanobiotechnology | journal | 1.490 Q2 | 109 | 10 | 39 | 361 | 177 | 37 | 5.44 | 36.10 | 34.09 | |
53 | Pharmaceutical Research | journal | 1.585 Q2 | 229 | 258 | 810 | 12028 | 3700 | 787 | 4.42 | 46.62 | 31.58 | |
52 | Pharmacogenetics and Genomics | journal | 1.593 Q2 | 152 | 116 | 332 | 4363 | 1606 | 327 | 4.53 | 37.61 | 39.73 | |
51 | NMR in Biomedicine | journal | 1.597 Q2 | 131 | 114 | 274 | 4708 | 1071 | 267 | 3.26 | 41.30 | 33.45 | |
50 | Nanomedicine: Nanotechnology, Biology, and Medicine | journal | 1.612 Q2 | 151 | 60 | 114 | 2107 | 637 | 111 | 6.10 | 35.12 | 33.83 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®